COMMUNIQUÉS West-GlobeNewswire

RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®
28/06/2018
RedHill has been granted the exclusive right to co-promote Mytesi ® (crofelemer 125 mg delayed-release tablets) in the U.S. to certain gastroenterologists and primary care physicians for the approved indication in [...]
Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study
28/06/2018
BARDA Funded Study Published in the Journal “Burns” SAN DIEGO, June 28, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) announced today the publication of preclinical data from a study using intravenous [...]
Konica Minolta Launches Portable Ultrasound with One-touch Image Optimization for Improved Workflow and Diagnostic Efficiency
28/06/2018
WAYNE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announces the introduction of the SONIMAGE® MX1 portable ultrasound system, optimized for musculoskeletal (MSK) and orthopedic [...]
BlissCo's International Cannabis Ecosystem Taking Shape -- CFN Media
28/06/2018
SEATTLE, June 28, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
AXIM® Biotechnologies to Present at 28th Annual International Cannabinoid Research Society Symposium in The Netherlands
28/06/2018
NEW YORK, June 28, 2018 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech ) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company will be attending as a [...]
XORTX Reports on Annual Special Meeting and Provides Corporate Update
28/06/2018
CALGARY, Alberta, June 28, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“ XORTX ” or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Rafael Pharmaceuticals Receives FDA Orphan Drug Designation for Treatment of Burkitt Lymphoma, and Initiates a Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia
28/06/2018
Newark, NJ, June 28, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has [...]
Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy
28/06/2018
QUEBEC CITY, Quebec, June 28, 2018 (GLOBE NEWSWIRE) -- Devonian Health Group Inc. (" Devonian " or the " Corporation ") (TSX VENTURE:GSD) and Folia Biotech inc. (‘‘Folia’’) today announce the signing of a non-binding [...]
Groupe Santé Devonian annonce la signature d’une lettre d’intention non contraignante avec Folia Biotech pour le développement du FB-631 en immunothérapie pour le cancer
28/06/2018
QUÉBEC, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- Groupe Santé Devonian inc. (« Devonian » ou la « Société ») (TSX CROISSANCE:GSD) a annoncé aujourd'hui la signature d'une lettre d'intention non contraignante (« lettre d [...]
Grandevo® CG and Venerate® CG for Pest Insect and Mite Control Cleared for Use on Cannabis by the Colorado, Oregon, Washington, Nevada, and Alaska Departments of Agriculture
28/06/2018
Grandevo® CG and Venerate® CG Are Effective Tools for Controlling Economically Damaging Mites and Insect Pests DAVIS, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a [...]
Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI® (palonosetron HCI) in the U.S.
28/06/2018
Helsinn Therapeutics (U.S.) Inc. becomes the exclusive distributor of ALOXI ® (palonosetron HCI) in the U.S. Iselin, NJ, USA, June 28, 2018 – Helsinn Therapeutics (U.S.) Inc., the U.S. subsidiary of Helsinn, a Swiss [...]
Celsion Corporation Announces Strategic Loan Facility
28/06/2018
$10 Million Improvement to the Balance Sheet Provides Additional Seven Months of Operating Runway LAWRENCEVILLE, N.J., June 28, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or “the Company”), [...]
Corvus Pharmaceuticals Announces Publication of Preclinical Study Results Demonstrating CPI-444 Antitumor Activity as Monotherapy and in Combination with Anti-PD-1 Therapy in Cancer Immunology, Immunotherapy
28/06/2018
Research elucidated novel mechanisms of CPI-444 indicating broad effects on several checkpoints BURLINGAME, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage [...]
International Endeavors Offers Equipment to Licensed Marijuana Growers
28/06/2018
TEMECULA, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC:IDVV) offers an innovative cooperative program for licensed marijuana growers to make use of the Off Grid [...]
GTX Corp Launches 2 New GPS Trackers for Kids SmartSole Now Available in Size Small
28/06/2018
LOS ANGELES, June 28, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an IoT platform and global provider of GPS tracking and monitoring wearable and wandering assistive technology, announces today the launch of the GPS [...]
Actinium Announces New Clinical Trial to Study Effect of Actimab-A on Minimal Residual Disease in Postremission AML Patients
28/06/2018
Minimal Residual Disease is increasingly recognized as a primary driver of high AML relapse rate highlighting need for improved consolidation therapies Webcast to be held on July 10, 2018 at 8:00 AM ET to discuss [...]
Retrotope Receives FDA Clearance to Commence RT001 Phase 2/3 Clinical Trial in Patients with Infantile Neuroaxonal Dystrophy (INAD)
28/06/2018
Patient enrollment anticipated to start in July 2018 LOS ALTOS, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Retrotope announced today that the U.S. Food and Drug Administration (FDA) has granted the company approval to [...]
BRACAnalysis® CDx Identifies Patients Who Respond to Lynparza® in SOLO-1 Study
28/06/2018
SALT LAKE CITY, June 28, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced that the Company’s BRACAnalysis ® CDx test identified responders to [...]
Amfora Unveils Broad Initiative to Develop Crops with Enhanced Protein Content for Food and Feed
28/06/2018
SAN FRANCISCO, June 28, 2018 (GLOBE NEWSWIRE) -- Amfora Inc., a biotechnology company committed to improving the nutritional content of food and feed crops, today unveiled a major new program to develop crops with [...]

Pages